MedWatch

Former Bavarian CFO: "Bioporto stuck out among the offers"

Ole Larsen has accepted an offer of becoming CFO in the diagnostics company Bioporto and will therefore leave his position as CFO at Bavarian Nordic. He considered going abroad but was convinced by the growth adventure that BioPorto hopes to embark on soon with an FDA approval.

Ole Larsen, new CFO at Bioporto. | Foto: Bavarian Nordic

The new CFO at Bioporto, Ole Larsen, considered positions both within Denmark and abroad. In the end he ended up accepting a position at the Danish diagnostics company.

"I have received inquiries from several places, and I have also looked at some opportunities abroad, but Bioporto stuck out among the offers," says Larsen to MedWatch.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Patienter må vente længere på ny medicin

Siden Medicinrådet blev etableret i 2017, er patienternes ventetid på ny medicin blevet tre gange længere, konkluderer en analyse fra Lif, der vil have Medicinrådet til at droppe unødvendige vurderingsmetoder. Medicinrådet arbejder på at nedbringe sagsbehandlingstiderne.

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier